Pacira BioSciences, Inc. (PCRX) — Cash Flow Reinvestment Rate
Pacira BioSciences, Inc. (PCRX) has a Cash Flow Reinvestment Rate of 0.25x as of June 2026, reinvesting $14.43 Million (capex $1.34 Million plus investments $13.10 Million) from operating cash flow of $57.46 Million. See Pacira BioSciences, Inc. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pacira BioSciences, Inc. Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Pacira BioSciences, Inc. across 12 annual periods. For the full cash flow conversion analysis, see Pacira BioSciences, Inc. (PCRX) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Pacira BioSciences, Inc. (2014–2025)
Year-by-year capital reinvestment analysis for Pacira BioSciences, Inc.. See Pacira BioSciences, Inc. (PCRX) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.97x | $146.85 Million | $151.99 Million | $15.33 Million | ▲ +94.8% |
| 2024 | 0.50x | $93.91 Million | $189.39 Million | $10.64 Million | ▼ -19.7% |
| 2023 | 0.62x | $95.52 Million | $154.65 Million | $15.16 Million | ▼ -64.8% |
| 2022 | 1.76x | $255.26 Million | $145.27 Million | $30.08 Million | ▼ -55.4% |
| 2021 | 3.94x | $494.98 Million | $125.72 Million | $45.87 Million | ▲ +9.3% |
| 2020 | 3.60x | $277.61 Million | $77.03 Million | $37.80 Million | ▲ +2180.7% |
| 2019 | 0.16x | $11.14 Million | $70.52 Million | $10.16 Million | ▼ -86.3% |
| 2018 | 1.16x | $56.45 Million | $48.87 Million | $14.51 Million | ▼ -89.7% |
| 2017 | 11.26x | $200.31 Million | $17.79 Million | $19.27 Million | ▲ +720.9% |
| 2016 | 1.37x | $45.90 Million | $33.45 Million | $24.71 Million | ▼ -42.7% |
| 2015 | 2.39x | $69.43 Million | $29.00 Million | $41.27 Million | ▼ -42.4% |
| 2014 | 4.16x | $105.91 Million | $25.47 Million | $21.89 Million | — |